160 related articles for article (PubMed ID: 16690616)
1. Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain.
van de Wijngaart DJ; van Royen ME; Hersmus R; Pike AC; Houtsmuller AB; Jenster G; Trapman J; Dubbink HJ
J Biol Chem; 2006 Jul; 281(28):19407-16. PubMed ID: 16690616
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
[TBL] [Abstract][Full Text] [Related]
3. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.
Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J
Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743
[TBL] [Abstract][Full Text] [Related]
4. Functional screening of FxxLF-like peptide motifs identifies SMARCD1/BAF60a as an androgen receptor cofactor that modulates TMPRSS2 expression.
van de Wijngaart DJ; Dubbink HJ; Molier M; de Vos C; Trapman J; Jenster G
Mol Endocrinol; 2009 Nov; 23(11):1776-86. PubMed ID: 19762545
[TBL] [Abstract][Full Text] [Related]
5. The FXXLF motif mediates androgen receptor-specific interactions with coregulators.
He B; Minges JT; Lee LW; Wilson EM
J Biol Chem; 2002 Mar; 277(12):10226-35. PubMed ID: 11779876
[TBL] [Abstract][Full Text] [Related]
6. Structural features discriminate androgen receptor N/C terminal and coactivator interactions.
Askew EB; Minges JT; Hnat AT; Wilson EM
Mol Cell Endocrinol; 2012 Jan; 348(2):403-10. PubMed ID: 21664945
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.
Hsu CL; Chen YL; Ting HJ; Lin WJ; Yang Z; Zhang Y; Wang L; Wu CT; Chang HC; Yeh S; Pimplikar SW; Chang C
Mol Endocrinol; 2005 Feb; 19(2):350-61. PubMed ID: 15514032
[TBL] [Abstract][Full Text] [Related]
8. Recognition and accommodation at the androgen receptor coactivator binding interface.
Hur E; Pfaff SJ; Payne ES; Grøn H; Buehrer BM; Fletterick RJ
PLoS Biol; 2004 Sep; 2(9):E274. PubMed ID: 15328534
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.
Estébanez-Perpiñá E; Moore JM; Mar E; Delgado-Rodrigues E; Nguyen P; Baxter JD; Buehrer BM; Webb P; Fletterick RJ; Guy RK
J Biol Chem; 2005 Mar; 280(9):8060-8. PubMed ID: 15563469
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of coregulator-induced conformational perturbations in androgen receptor ligand binding domain.
Zakharov MN; Pillai BK; Bhasin S; Ulloor J; Istomin AY; Guo C; Godzik A; Kumar R; Jasuja R
Mol Cell Endocrinol; 2011 Jul; 341(1-2):1-8. PubMed ID: 21605623
[TBL] [Abstract][Full Text] [Related]
11. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region.
Wang Q; Lu J; Yong EL
J Biol Chem; 2001 Mar; 276(10):7493-9. PubMed ID: 11102454
[TBL] [Abstract][Full Text] [Related]
12. The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs.
Hsu CL; Chen YL; Yeh S; Ting HJ; Hu YC; Lin H; Wang X; Chang C
J Biol Chem; 2003 Jun; 278(26):23691-8. PubMed ID: 12714604
[TBL] [Abstract][Full Text] [Related]
13. The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
Ozers MS; Marks BD; Gowda K; Kupcho KR; Ervin KM; De Rosier T; Qadir N; Eliason HC; Riddle SM; Shekhani MS
Biochemistry; 2007 Jan; 46(3):683-95. PubMed ID: 17223690
[TBL] [Abstract][Full Text] [Related]
14. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
Zhou ZX; He B; Hall SH; Wilson EM; French FS
Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
[TBL] [Abstract][Full Text] [Related]
15. Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.
Askew EB; Gampe RT; Stanley TB; Faggart JL; Wilson EM
J Biol Chem; 2007 Aug; 282(35):25801-16. PubMed ID: 17591767
[TBL] [Abstract][Full Text] [Related]
16. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs.
He B; Wilson EM
Mol Cell Biol; 2003 Mar; 23(6):2135-50. PubMed ID: 12612084
[TBL] [Abstract][Full Text] [Related]
17. The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions.
Schaufele F; Carbonell X; Guerbadot M; Borngraeber S; Chapman MS; Ma AA; Miner JN; Diamond MI
Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9802-7. PubMed ID: 15994236
[TBL] [Abstract][Full Text] [Related]
18. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.
He B; Kemppainen JA; Wilson EM
J Biol Chem; 2000 Jul; 275(30):22986-94. PubMed ID: 10816582
[TBL] [Abstract][Full Text] [Related]
19. Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity.
Ting HJ; Bao BY; Hsu CL; Lee YF
Endocrine; 2005 Feb; 26(1):1-9. PubMed ID: 15805579
[TBL] [Abstract][Full Text] [Related]
20. Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.
Jääskeläinen J; Deeb A; Schwabe JW; Mongan NP; Martin H; Hughes IA
J Mol Endocrinol; 2006 Apr; 36(2):361-8. PubMed ID: 16595706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
